New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2013
11:42 EDTAMAGAMAG sees FY13 revenue $73M- $77M, consensus $79.12M
AMAG sees Feraheme U.S. net product revenues of between $63M-$67M, driven by a combination of price and double-digit volume growth; Royalties and product sales related to ex-U.S. sales of Feraheme/Rienso and recognition of milestones of approximately $10M.
News For AMAG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for AMAG

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use